WallStreetZenWallStreetZen

NASDAQ: ADPT
Adaptive Biotechnologies Corp Stock Ownership - Who owns Adaptive Biotechnologies?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Adaptive Biotechnologies Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Susan BobulskyCCO2026-08-103,000$25.00
$75.00kSell
Susan BobulskyCCO2026-07-301,299$24.00
$31.18kSell
Harlan S. RobinsCSci2026-07-21213,702$22.12
$4.73MSell
Harlan S. RobinsCSci2026-07-21284,800$6.55
$1.87MBuy
Harlan S. RobinsCSci2026-07-21278,698$21.72
$6.05MSell
Susan BobulskyCCO2026-07-165,000$23.00
$115.00kSell
Francis LoCHRO2026-07-1523,677$12.14
$287.44kBuy
Francis LoCHRO2026-07-1559,374$7.80
$463.12kBuy
Francis LoCHRO2026-07-1522,711$8.46
$192.14kBuy
Francis LoCHRO2026-07-15105,762$22.59
$2.39MSell

1 of 22

ADPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADPT insiders and whales buy or sell their stock.

ADPT Shareholders

What type of owners hold Adaptive Biotechnologies Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Viking Global Performance LLC19.42%30,993,708$766.78MInsider
Viking Global Investors LP18.79%29,993,708$742.04MInsider
David E. Goel7.71%12,310,594$304.56MInsider
Chad M. Robins3.52%5,618,018$138.99MInsider
Andris A. Zoltners2.27%3,621,016$89.58MInsider
Harlan S. Robins1.01%1,612,058$39.88MInsider
Wasatch Advisors LP0.36%576,266$14.26MInstitution
Tycho Peterson0.33%531,553$13.15MInsider
Susan Bobulsky0.25%396,989$9.82MInsider
Peregrine Capital Management LLC0.25%393,095$9.73MInstitution

1 of 3

ADPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADPT0.10%54.71%Net SellingNet Selling
LEGN0.03%0.15%Net SellingNet Selling
DNLI0.10%57.29%Net SellingNet Selling
TLX0.00%7.56%Net Buying
GPCR0.03%10.38%Net SellingNet Buying
View Top Biotech Stocks

Adaptive Biotechnologies Stock Ownership FAQ

Who owns Adaptive Biotechnologies?

Adaptive Biotechnologies (NASDAQ: ADPT) is owned by 0.10% institutional shareholders, 54.71% Adaptive Biotechnologies insiders, and 45.19% retail investors. Viking Global Performance LLC is the largest individual Adaptive Biotechnologies shareholder, owning 30.99M shares representing 19.42% of the company. Viking Global Performance LLC's Adaptive Biotechnologies shares are currently valued at $766.78M.

If you're new to stock investing, here's how to buy Adaptive Biotechnologies stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.